Eunice Kennedy Shriver National Institute of Child Health and Human Development:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Eunice Kennedy Shriver National Institute of Child Health and Human Development - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C5169
◆発行会社(調査会社):GlobalData
◆発行日:2018年9月
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), a subsidiary of National Institutes of Health, is a research institute that conducts and supports laboratory research, clinical trials, and epidemiological studies. The institute conducts research in the fields of fields of reducing infant deaths, improving health of women, men and families learning. It offers research in clinical trials and clinical research, health education campaigns and programs, NICHD publications, scientific research planning and scientific resources. NICHD also provides funding support for training and career development activities at universities and other institutions. The institute offers its services for laboratory research, clinical trials and studies. NICHD is headquartered in Rockville, Maryland, the US.

Eunice Kennedy Shriver National Institute of Child Health and Human Development – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Cyprium Therapeutics Enters into Research and Development Agreement with Eunice Kennedy Shriver NICHD 11
SRI International Enters into Biological Testing Facility Contract with NICHD 12
Dimension Therapeutics Enters into R&D Agreement with Eunice Kennedy Shriver National Institute 13
Licensing Agreements 14
NICHD Enters into Licensing Agreement with Cyprium Therapeutics 14
Eunice Kennedy Shriver National Institute of Child Health and Human Development – Key Competitors 15
Eunice Kennedy Shriver National Institute of Child Health and Human Development – Key Employees 16
Eunice Kennedy Shriver National Institute of Child Health and Human Development – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Research And Development 18
Jan 06, 2017: Viriom Announces Collaboration with NIH on Zika and Other Major Viral Diseases 18
Government and Public Interest 19
Jul 02, 2018: Pregnancy Loss Occurs in 26 Percent of Zika-Infected Monkeys 19
Jun 13, 2018: New trans-NIH consortium aims to advance pediatric research on a global level 20
May 09, 2018: Dr. Boukrina of Kessler Foundation Explores Intervention for Reading Deficits After Stroke 21
Apr 11, 2018: NIH researchers crack mystery behind rare bone disorder 22
Apr 02, 2018: Elevated blood pressure before pregnancy may increase chance of pregnancy loss 23
Mar 29, 2018: NIH study may help explain why iron can worsen malaria infection 24
Mar 26, 2018: Atypical brain development observed in preschoolers with ADHD symptoms 25
Mar 26, 2018: Diuretic therapy for extremely preterm infants does not alleviate respiratory problems 26
Mar 12, 2018: CRISPR helps find new genetic suspects behind ALS/FTD 27
Mar 07, 2018: Antiviral drug not beneficial for reducing mother-to-child transmission of hepatitis B when added to existing preventatives 28
Feb 13, 2018: NIH-funded researchers identify risk factors for sleep apnea during pregnancy 29
Nov 13, 2017: Obesity during pregnancy may lead directly to fetal overgrowth, NIH study suggests 30
May 25, 2017: Investigator Lawrence T. Reiter, PhD, of The University of Tennessee Health Science Center Receives $418,000 Grant for New Antieplieptic Drug Treatment Study 31
Product News 32
03/23/2018: Male Birth Control Pill Shows Promise 32
03/18/2018: Dimethandrolone undecanoate shows promise as a male birth control pill 33
Feb 26, 2018: NIH researchers find a potential treatment for disorders involving excess red blood cells 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Pharmaceuticals & Healthcare, Key Facts 2
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Deals By Therapy Area, 2012 to YTD 2018 9
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Cyprium Therapeutics Enters into Research and Development Agreement with Eunice Kennedy Shriver NICHD 11
SRI International Enters into Biological Testing Facility Contract with NICHD 12
Dimension Therapeutics Enters into R&D Agreement with Eunice Kennedy Shriver National Institute 13
NICHD Enters into Licensing Agreement with Cyprium Therapeutics 14
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Key Competitors 15
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Key Employees 16
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Subsidiaries 17

List of Figures
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

★海外企業調査レポート[Eunice Kennedy Shriver National Institute of Child Health and Human Development:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Broadwind Energy, Inc. (BWEN)-エネルギー分野:企業M&A・提携分析
    Summary Broadwind Energy, Inc. (Broadwind) is a precision manufacturer of structures, equipment, and components for clean technology and other specialized applications. It offers a wide range of products from gears and gearing systems, to wind turbine towers, fabrications and industrial weldments. B …
  • Alcoa Corp:企業の戦略・SWOT・財務情報
    Alcoa Corp - Strategy, SWOT and Corporate Finance Report Summary Alcoa Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Hokkaido Gas Co Ltd (9534):企業の財務・戦略的SWOT分析
    Summary Hokkaido Gas Co Ltd (Hokkaido Gas), a subsidiary of Kita Gas Group is an oil and gas company that distributes petroleum products. The company’s business activities include gas business, heat supply, power supply, purification and sale of gas by-products, and production and sale of gas applia …
  • Compagnie Des Alpes Sa:企業の戦略・SWOT・財務分析
    Compagnie Des Alpes Sa - Strategy, SWOT and Corporate Finance Report Summary Compagnie Des Alpes Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • 3i Group Plc:企業のM&A・事業提携・投資動向
    3i Group Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's 3i Group Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Checkpoint Surgical LLC-医療機器分野:企業M&A・提携分析
    Summary Checkpoint Surgical LLC (Checkpoint Surgical) is a medical device company that offers neuro-protective surgery equipment. The company offers neuro-protective devices including checkpoint stimulators and locators; and checkpoint head and neck systems. Its checkpoint stimulators and locators p …
  • Waterloo Industries Inc:企業の戦略的SWOT分析
    Waterloo Industries Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Turbo Power Systems Ltd:企業の戦略的SWOT分析
    Turbo Power Systems Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Arab Petroleum Investments Corp:企業の戦略的SWOT分析
    Arab Petroleum Investments Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Sc Arcada Con Srl:企業の戦略的SWOT分析
    Sc Arcada Con Srl - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Oglethorpe Power Corporation:企業の戦略・SWOT・財務分析
    Oglethorpe Power Corporation - Strategy, SWOT and Corporate Finance Report Summary Oglethorpe Power Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Biolase Inc (BIOL):医療機器:M&Aディール及び事業提携情報
    Summary Biolase Inc (Biolase) develops, manufactures, markets and sells dental lasers and related products. It also distributes dental imaging equipment, including cone beam digital x-rays and CAD/CAM intra-oral scanners. The company offers two categories of laser systems: WaterLase systems and Diod …
  • Societe Electrique de l’Our SA:企業の戦略的SWOT分析
    Societe Electrique de l'Our SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • eFFECTOR Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary eFFECTOR Therapeutics Inc (eFFECTOR) is a clinical-stage biopharmaceutical company that focuses on the discovery and development of selective translation regulators for the treatment of cancer. Its investigational compounds are designed to restore the translational control of processes that …
  • Sorgenia SpA:企業の戦略的SWOT分析
    Sorgenia SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Energa SA (ENG):企業の財務・戦略的SWOT分析
    Energa SA (ENG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Evonik Industries Ag:企業の戦略・SWOT・財務分析
    Evonik Industries Ag - Strategy, SWOT and Corporate Finance Report Summary Evonik Industries Ag - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Housing Development Finance Corporation Ltd:企業の戦略・SWOT・財務情報
    Housing Development Finance Corporation Ltd - Strategy, SWOT and Corporate Finance Report Summary Housing Development Finance Corporation Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • VistaGen Therapeutics Inc (VTGN):企業の財務・戦略的SWOT分析
    Summary VistaGen Therapeutics Inc (VistaGen) is a clinical stage biopharmaceutical company that develops new generation medicines for depression and neuropsychiatric disorders. The company’s pipeline product, AV-101, currently under Phase 2 clinical development, is an oral N-methyl-D-aspartate recep …
  • KBC Group NV:企業のM&A・事業提携・投資動向
    KBC Group NV - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's KBC Group NV Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆